Literature DB >> 28228275

RSV Takes Control of Neonatal Breg Cells: Two Hands on the Wheel.

Peter J M Openshaw1.   

Abstract

The viral attachment protein of RSV has many surprising features, especially its mimicry of fractalkine (CX3CL1). Zhivaki et al. (2017) now show that, in addition to using this homology to attach to ciliated cells, it activates human neonatal regulatory B cells, thereby inhibiting immunological responses.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2017        PMID： 28228275      PMCID： PMC7612800          DOI： 10.1016/j.immuni.2017.01.011

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   43.474


  9 in total

Review 1.  Regulatory B cells: origin, phenotype, and function.

Authors:  Elizabeth C Rosser; Claudia Mauri
Journal:  Immunity       Date:  2015-04-21       Impact factor: 31.745

2.  CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein.

Authors:  R A Tripp; L P Jones; L M Haynes; H Zheng; P M Murphy; L J Anderson
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 3.  Protective and Harmful Immunity to RSV Infection.

Authors:  Peter J M Openshaw; Chris Chiu; Fiona J Culley; Cecilia Johansson
Journal:  Annu Rev Immunol       Date:  2017-02-06       Impact factor: 28.527

4.  Persistent infection of B lymphocytes by bovine respiratory syncytial virus.

Authors:  J F Valarcher; H Bourhy; A Lavenu; N Bourges-Abella; M Roth; O Andreoletti; P Ave; F Schelcher
Journal:  Virology       Date:  2001-12-05       Impact factor: 3.616

Review 5.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

6.  Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

Authors:  T E Sparer; S Matthews; T Hussell; A J Rae; B Garcia-Barreno; J A Melero; P J Openshaw
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

7.  CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner.

Authors:  Kwang-Il Jeong; Peter A Piepenhagen; Michael Kishko; Joshua M DiNapoli; Rachel P Groppo; Linong Zhang; Jeffrey Almond; Harry Kleanthous; Simon Delagrave; Mark Parrington
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity.

Authors:  Dania Zhivaki; Sébastien Lemoine; Annick Lim; Ahsen Morva; Pierre-Olivier Vidalain; Liliane Schandene; Nicoletta Casartelli; Marie-Anne Rameix-Welti; Pierre-Louis Hervé; Edith Dériaud; Benoit Beitz; Maryline Ripaux-Lefevre; Jordi Miatello; Brigitte Lemercier; Valerie Lorin; Delphyne Descamps; Jenna Fix; Jean-François Eléouët; Sabine Riffault; Olivier Schwartz; Fabrice Porcheray; Françoise Mascart; Hugo Mouquet; Xiaoming Zhang; Pierre Tissières; Richard Lo-Man
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

9.  Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

Authors:  Sara M Johnson; Beth A McNally; Ioannis Ioannidis; Emilio Flano; Michael N Teng; Antonius G Oomens; Edward E Walsh; Mark E Peeples
Journal:  PLoS Pathog       Date:  2015-12-11       Impact factor: 6.823
  9 in total
  2 in total

1.  Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Authors:  Kedir N Turi; Jyoti Shankar; Larry J Anderson; Devi Rajan; Kelsey Gaston; Tebeb Gebretsadik; Suman R Das; Cosby Stone; Emma K Larkin; Christian Rosas-Salazar; Steven M Brunwasser; Martin L Moore; R Stokes Peebles; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

Review 2.  Mucosal Immune Responses to Respiratory Syncytial Virus.

Authors:  Megan V C Barnes; Peter J M Openshaw; Ryan S Thwaites
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.